FRA
Frank Rimerman Advisors Portfolio holdings
AUM
$1.49B
This Quarter Return
+14.52%
1 Year Return
+25.09%
3 Year Return
+115.63%
5 Year Return
–
10 Year Return
–
AUM
$479M
AUM Growth
+$479M
(+16%)
Cap. Flow
+$6.7M
Cap. Flow
% of AUM
1.4%
Top 10 Holdings %
Top 10 Hldgs %
70.49%
Holding
318
New
217
Increased
26
Reduced
10
Closed
3
Top Buys
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
$1.26M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$1.12M |
| 3 |
Vanguard Total Bond Market
BND
|
$1.02M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$915K |
| 5 |
Broadcom
AVGO
|
$904K |
Top Sells
| 1 |
SentinelOne
S
|
$5.13M |
| 2 |
Procore
PCOR
|
$521K |
| 3 |
VanEck Fallen Angel High Yield Bond ETF
ANGL
|
$424K |
| 4 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
$408K |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$253K |
Sector Composition
| 1 | Communication Services | 13.03% |
| 2 | Technology | 9.09% |
| 3 | Healthcare | 4.5% |
| 4 | Consumer Discretionary | 0.95% |
| 5 | Financials | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Abbott
ABT
$229B
| $8.04K | ﹤0.01% |
+73
| New | +$8.04K |
|
177
Chubb
CB
$110B
| $7.91K | ﹤0.01% |
+35
| New | +$7.91K |
|
178
CVS Health
CVS
$94B
| $7.82K | ﹤0.01% |
+99
| New | +$7.82K |
|
179
Goldman Sachs
GS
$221B
| $7.72K | ﹤0.01% |
+20
| New | +$7.72K |
|
180
Colgate-Palmolive
CL
$68.2B
| $7.49K | ﹤0.01% |
+94
| New | +$7.49K |
|
181
Linde
LIN
$222B
| $7.39K | ﹤0.01% |
+18
| New | +$7.39K |
|
182
Union Pacific
UNP
$132B
| $7.37K | ﹤0.01% |
+30
| New | +$7.37K |
|
183
Blackrock
BLK
$173B
| $7.31K | ﹤0.01% |
+9
| New | +$7.31K |
|
184
American Express
AXP
$230B
| $7.12K | ﹤0.01% |
+38
| New | +$7.12K |
|
185
Illinois Tool Works
ITW
$76.4B
| $7.07K | ﹤0.01% |
+27
| New | +$7.07K |
|
186
Northrop Grumman
NOC
$84.4B
| $7.02K | ﹤0.01% |
+15
| New | +$7.02K |
|
187
Copart
CPRT
$46.9B
| $6.47K | ﹤0.01% |
+132
| New | +$6.47K |
|
188
Cognizant
CTSH
$35.1B
| $6.27K | ﹤0.01% |
+83
| New | +$6.27K |
|
189
Lam Research
LRCX
$123B
| $6.27K | ﹤0.01% |
+8
| New | +$6.27K |
|
190
MetLife
MET
$53.6B
| $6.22K | ﹤0.01% |
+94
| New | +$6.22K |
|
191
Bristol-Myers Squibb
BMY
$96.5B
| $5.75K | ﹤0.01% |
+112
| New | +$5.75K |
|
192
PNC Financial Services
PNC
$80.9B
| $5.73K | ﹤0.01% |
+37
| New | +$5.73K |
|
193
S&P Global
SPGI
$165B
| $5.73K | ﹤0.01% |
+13
| New | +$5.73K |
|
194
AbbVie
ABBV
$374B
| $5.58K | ﹤0.01% |
+36
| New | +$5.58K |
|
195
Marsh & McLennan
MMC
$101B
| $5.5K | ﹤0.01% |
+29
| New | +$5.5K |
|
196
Elevance Health
ELV
$72.6B
| $5.19K | ﹤0.01% |
+11
| New | +$5.19K |
|
197
Ametek
AME
$42.7B
| $5.11K | ﹤0.01% |
+31
| New | +$5.11K |
|
198
TJX Companies
TJX
$155B
| $5.07K | ﹤0.01% |
+54
| New | +$5.07K |
|
199
Eaton
ETN
$134B
| $5.06K | ﹤0.01% |
+21
| New | +$5.06K |
|
200
Automatic Data Processing
ADP
$121B
| $4.89K | ﹤0.01% |
+21
| New | +$4.89K |
|